A
Alcista
Alcista · 25%EVH
$10.23
Precio del escenario
$4.870
+0.144 (+2.96%)Al cierre
Loading chart…
- Máximo
- 5.115
- Apertura
- 4.750
- Precio medio ponderado por volumen
- 4.91
- Volumen
- 3.84M
- Capitalización
- 2.30B
- Mínimo
- 4.750
- Importe
- 18.85M
- EV/EBITDA, TTM
- 20.06
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers primary solutions, including specialty care management services and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
Análisis de IA of Evolent Health Inc (EVH)
ComprarEvolent Health Inc is a good buy right now, as it is currently priced at $4.04 with a 5-day change of +16.76%, indicating positive momentum. The forward P/E ratio is 8.62, suggesting it is undervalued compared to its earnings potential. However, the main risk is its high net debt-to-EBITDA ratio of 7x, which could lead to challenges in raising capital if market conditions worsen.
Recomendaciones de analistas (13)
+91.58% de potencial alcista
Comprar
13 Comprar
0 Mantener
0 Vender
Actual: 4.87
Mínimo
5.00
Promedio
9.33
Máximo
16.00
Citi
Comprar
$6
2026-08-10
Citi
2026-08-10
Precio objetivo
$6
Comprar
Canaccord
Comprar
$6
2026-08-10
Canaccord
2026-08-10
Precio objetivo
$6
Comprar
TD Cowen
Comprar
$5
2026-07-28
TD Cowen
2026-07-28
Precio objetivo
$5
Comprar
Citi
Neutral
—
2026-07-23
Citi
2026-07-23
Precio objetivo
—
Neutral
Canaccord
Comprar
$7
2026-07-21
Canaccord
2026-07-21
Precio objetivo
$7
Comprar
Métricas de valoración
El PER previsto actual de Evolent Health Inc (EVH) es 8.62, frente a su media de 5 años de 73.95.
Escenarios de precio de Alphio AI para EVH
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Ballenas con EVH en cartera
Cronología de eventos
Noticias
9.510-09PRnewswireEvolent Health to Release Q3 2026 Financial Results on November 5
7.509-21PRnewswireExpanded Partnership Enhances Language Access Across Evolent's Network
7.509-21NewsfilterEvolent Expands Partnership with TransPerfect to Enhance Language Access
6.508-16Yahoo FinanceHealthcare Stock Investment Opportunities and Risks Analysis
2.008-13NASDAQ.COMEvolent Health (EVH) Q2 2026 Earnings Call Transcript
Preguntas frecuentes sobre EVH, respondidas por Alphio AI
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers primary solutions, including specialty care management services and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner. It operates in the Healthcare sector (SERVICES-MANAGEMENT SERVICES industry).
Evolent Health Inc is a good buy right now, as it is currently priced at $4.04 with a 5-day change of +16.76%, indicating positive momentum. The forward P/E ratio is 8.62, suggesting it is undervalued compared to its earnings potential. However, the main risk is its high net debt-to-EBITDA ratio of 7x, which could lead to challenges in raising capital if market conditions worsen.
13 analysts cover EVH: 13 rate it Buy, 0 Hold and 0 Sell. The average price target is 9.33.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.